Back to top
Contact us

Solutions

Transforming behavioral health research, innovation & care

Holmusk's unique suite of solutions combines cutting-edge digital tools with next-generation analytics, making unprecedented innovation possible.

Real-World Evidence Platform

NeuroBlu is a data and analytics platform that enables uniquely powerful evidence generation. With the leading behavioral health database enriched with peer-reviewed proprietary NLP, NeuroBlu gives researchers, pharma, clinicians, and other industry partners the ability to create insights like never before.

Abstract representation of a non-linear research approach

Explore

Delve into a rich, unique database in an easy-to-use interface designed for fast and scalable inquiries

Analyze

Investigate research questions and enhance care delivery with state-of-the-art analytics tools, including our proprietary NLP and AI/ML algorithms which seamlessly integrates into our solutions

Discover

Generate insights with longitudinal severity scores and NLP-derived signs and symptoms, external stressors, and side effects

Product Features

Data Explorer showcasing multiple number of data tables available,

View data and get high-level summaries of the dataset, including a set of visualizations describing the population characteristics

Cohort Builder interface with updated statistics based on the user's cohort selection.

Intuitive graphical interface allowing you to build your study cohort using a few clicks, and view cohort characteristics with charts updated in real-time

Category Mapper that shows antidepressant drugs selected.

Simple and streamlined tool to build groupings of values (e.g., diagnosis codes or drug type) to create custom categories for use across multiple projects in a simple and less error-prone way

R Code interface that showcases the code panel with different types of files such as 'R', CSV, Image.

Perform custom analytics in R or Python with your own code or from our built-in library of code templates for popular studies

VALUE

Bring Treatments to Market Faster with Real-World Evidence

Powerful insights to drive clinical and commercial success in life sciences, and improve care delivery.

Research and Development

Support clinical development and increase success of trial designs.

R&D Strategy

  • Identify patient subsegments with unmet needs, such as opioid use disorder patient with poor outcomes despite being on a treatment regimen.

Clinical Development

  • Significantly accelerate clinical trial recruitment by screening patient characteristics efficiently. For instance, easily identify characteristics of patients with Major Depressive Disorder who display symptoms of anhedonia.
  • Understand characteristics associated with varying levels of severity in patients with Major Depressive Disorder, in order to create patient subsegments to inform trial design for compounds targeting treatment-resistant depression.

Medical Affairs

Derive patient specific insights and population level trends in behavioral health using AI/ML algorithms on large sets of real-world behavioral health data.

  • Compare key endpoints — such as Clinical Global Impression-Severity (CGI-S), Global Assessment of Function (GAF), and side effect burden — for patients on competitor drugs to provide evidence of differentiated benefit.
  • Assess patient-centric endpoints — such as mood, function, and engagement — that can significantly impact outcomes in real-world settings, including treatment adherence, clinician prescription decisions, and overall patient health.
  • Evaluate prescription patterns of off-label drugs for Major Depressive Disorder to identify related behavioral health indications for further clinical evaluation.
  • Guide evidence-driven care to enhance care management for patients at risk and to improve behavioral health outcomes.
  • Produce publications highlighting therapeutic benefit in real-world settings to increase impact factor with key opinion leaders and other health care professionals.

Market Access and HEOR

Evaluate comparative effectiveness of pharmacological treatments in the real world and enable value-based care.

  • Establish cost-benefit by determining comparative effectiveness of treatments beyond standard clinical endpoints, such as hospitalization among patients on different drug formulations (e.g. oral versus long-acting injectable atypical antipsychotics).
  • Measure drug performance in real-world settings and identify opportunities for value-based strategies.

Value

Bring Treatments to Market Faster with Real-World Evidence

Powerful insights to drive clinical and commercial success in life sciences, and improve care delivery.

Research and Development

Medical Affairs

Market Access and HEOR

Learn More

A³S: Analytics-as-a-Service

Tap into our data science and AI/ML expertise for custom advanced analytics.

Our expertise, your needs

We work collaboratively with you to generate evidence that matters, so you can get to insights and value quickly

Customizable

We support both short-term analytic projects and long-term collaborations with a dedicated data science team

Publication-quality

We strive to meet publication quality and frequently publish peer-reviewed papers with research partners

Data science designed with purpose

Our proprietary analytics approaches are specifically designed to transform behavioral health Real-World Data into clinically meaningful and transformative insights.

Starting from knowledge, not black boxes

Unlocking new possibilities with NLP

Analytics rigor for real world impact

Specialty EHR & Digital Solutions

EHR

HolCare EHR+ is a cloud-based, state-of-the-art electronic health record platform designed to meet the needs of mental health agencies, telepsychiatry groups, research organizations, and other disruptive care models.

Built-in Measurement-Based Care (MBC)

MBC has been proven to improve care, increase response to treatment, help clinicians make better decisions, and contribute to better outcomes. However, when not integrated directly into an EHR, MBC is challenging to implement and can diminish productivity. HolCare EHR+ solves for this problem with fully integrated MBC, providing an easy way to collect measures that are meaningful to patient care.

Superior Interoperability for Healthcare

HL7 FHIR native support enables the use of any third-party health care technology. This standard eliminates the need for expensive, time-consuming “custom integrations” in favor of a platform that can share both clinical and non-clinical data with partners.

Digital Solution

mConnect is a digital solution designed to provide more personalized care and improve outcomes with integrated digital and clinical data.

Activating patients

mConnect engages patients in managing their own care, enabling them to track and share symptoms, side effects, quality of life, and other measures that matter to them with their clinicians

Guiding clinical decisions

mConnect integrates patient-reported outcomes with clinical data from the EHR into a user-friendly dashboard, to enable Measurement Based Care (MBC) and facilitate personalized treatment decisions

Digital Solution

mHaven empowers individuals with the support, education and motivation to take control of their mental and emotional well-being. mHaven provides well-being assessments, risk segmentation, personalized feedback, educational content, and coaching features.

Digital Solution

FoodDX is an AI platform to transform the way people manage food choices and food-related behaviors, with AI-based real-time food photo scoring, smart food tips, and personalized nutrition coaching.

Digital Solution

GlycoLeap is a digital therapeutic program that supports and empowers people living with chronic metabolic diseases like diabetes, pre-diabetes, and obesity to make sustainable behavioral changes for a healthier life.